SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein

CAT:
223-10-075
Size:
0.1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: Yes
SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein - image 1

SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein

  • Background:

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD) . The CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells 3-5. Although both SARS-CoV and SARS-CoV-2 bind the ACE2 receptor, the RBDs only share ~73% amino acid identity, and the SARS-CoV-2 RBD binds with a higher affinity compared to SARS-CoV 3, 6. The RBD is dynamic and undergoes hinge-like conformational changes, referred to as the “down” or “up” conformations, which hide or expose the receptor-binding motifs, respectively 7. Following receptor binding, S1 destabilizes, and TMPRSS2 cleaves S2, which undergoes a pre- to post-fusion conformation transition, allowing for membrane fusion 8, 9. The S protein has been the main focus of therapeutic and vaccine design as it is highly immunogenic. Both neutralizing antibodies 10,11 and memory T cells 12,13 targeting the S protein are present in the sera of convalescent COVID-19 patients.
  • NCBI Gene ID:

    1791269090
  • Accession Number:

    QHD43416.1
  • Type:

    Recombinant Proteins
  • Source:

    HEK293 cells
  • Field of Research:

    Infectious Disease, COVID-19
  • Buffer:

    This recombinant protein is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added.
  • Shipping Conditions:

    Dry Ice
  • Storage Conditions:

    This recombinant protein may be stored as received at 2-8˚ C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80˚ C. Avoid Repeated Freeze Thaw Cycles.
  • Calculated Molecular Weight:

    The predicted molecular mass is ~132 kDa for monomer and ~396 kDa for trimer
  • Applications Notes:

    ELISA
  • NCBI Official Name:

    Surface glycoprotein
  • NCBI Organism:

    Severe acute respiratory syndrome coronavirus 2
  • Background Reference 01:

    Zhou, P., Yang, X., Wang, X. et al. Nature 579, 270–273. 2020.
  • Background Reference 02:

    Wu, F., Zhao, S., Yu, B. et al. Nature 579, 265–269. 2020.
  • Background Reference 03:

    Wrapp D, Wang N, Corbett KS, et al. bioRxiv. 2020.02.11.944462. 2020.
  • Background Reference 04:

    Walls AC, Park YJ, Tortorici MA, et al. Cell. 181 (2) :281-292.e6. 2020.
  • Tested Applications:

    ELISA
  • Species:

    SARS-CoV-2
  • Physical Properties:

    Liquid
  • CAS Number:

    9000-83-3